Lenvima 10 mg (Lenvatinib) – Information for Patients in Birmingham & London
Lenvima 10 mg, containing the active ingredient lenvatinib, is an oral prescription medicine used in oncology. Lenvima is available as hard capsules containing 10 mg of lenvatinib.
For patients and families searching for information about Lenvima 10 mg in Birmingham or Lenvima 10 mg in London, it is important to understand that this medicine should only be used under appropriate medical supervision.
Lenvima 10 mg in Birmingham
People searching online for Lenvima 10 mg Birmingham, Lenvatinib 10 mg Birmingham, or Lenvima cancer treatment information Birmingham should consult their oncology team or pharmacist for advice about whether lenvatinib is appropriate for their individual condition.
Lenvatinib is a tyrosine-kinase inhibitor that acts on several receptor pathways involved in tumour growth and blood-vessel formation.
Lenvima 10 mg in London
For searches such as Lenvima 10 mg London, Lenvatinib 10 mg London, and Lenvima oncology medicine London, patients should obtain medicine only through appropriate prescription and pharmaceutical channels.
The EMA states that Lenvima treatment must be started and supervised by a doctor experienced in using cancer medicines.
What is Lenvima 10 mg used for?
Depending on the authorised indication, Lenvima may be used for certain adults with:
Differentiated thyroid carcinoma that is locally advanced or metastatic and refractory to radioactive iodine.
Advanced or unresectable hepatocellular carcinoma in specified treatment circumstances.
Advanced or recurrent endometrial carcinoma in combination with pembrolizumab in specified circumstances.
The appropriate dose and treatment schedule depend on the patient's diagnosis, treatment history, clinical condition and other medicines.
Lenvatinib 10 mg: Important Safety Information
Lenvima can cause adverse effects and requires medical monitoring. Reported adverse effects include high blood pressure, diarrhoea, decreased appetite and weight, fatigue, nausea, protein in the urine, mouth inflammation, vomiting, voice changes and hand-foot syndrome. Serious complications can also occur.
Patients should not change their dose, stop treatment or restart treatment without discussing this with their treating healthcare professional.
Lenvima 10 mg searches across the UK
Common informational searches may include:
Lenvima 10 mg Birmingham | Lenvima 10 mg London | Lenvatinib 10 mg Birmingham | Lenvatinib 10 mg London | Lenvima capsules UK | Lenvatinib cancer medicine UK | Lenvima oncology treatment | Lenvatinib prescription information | Lenvima patient information | Lenvatinib safety information
Frequently Asked Questions
What is Lenvima 10 mg?
Lenvima 10 mg is a hard capsule containing 10 mg of lenvatinib, an oncology medicine belonging to the tyrosine-kinase inhibitor class.
Is Lenvima 10 mg a prescription medicine?
Yes. The EMA states that Lenvima can only be obtained with a prescription and that treatment should be started and supervised by an appropriately experienced doctor.
What is lenvatinib used for?
Lenvatinib is used for specific cancers, including certain differentiated thyroid cancers and hepatocellular carcinoma, with additional authorised uses in combination with pembrolizumab for specified endometrial cancer patients.
Can I decide my Lenvima dose myself?
No. The dose is determined by the treating healthcare professional according to the indication and the patient's circumstances. Dose reductions or treatment interruptions may sometimes be required to manage adverse effects.
Where can I find official information about Lenvima?
Patients in Birmingham, London and elsewhere in the UK can consult their oncologist, pharmacist or the official medicine information supplied by the relevant medicines regulator.
Patient Information
This page is for general educational purposes and does not replace advice from an oncologist, doctor or pharmacist. Lenvima should be used only when prescribed and under appropriate medical supervision.
Official reference: European Medicines Agency — Lenvima product information and medicine overview.
Vision Pharma contact information supplied for general enquiries:
Email: visionpharmaglobal@gmail.com
Phone: +91 9326646654
